Circulating Brain Injury Exosomal Proteins following Moderate-to-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy Implications
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Brain injury exosomal proteins are promising blood biomarker candidates in traumatic brain injury (TBI). A better understanding of their role in the diagnosis, characterization, and management of TBI is essential for upcoming clinical implementation. In the current investigation, we aimed to explore longitudinal trajectories of brain injury exosomal proteins in blood of patients with moderate-to-severe TBI, and to evaluate the relation with the free-circulating counterpart and patient imaging and clinical parameters. Exosomal levels of glial (glial fibrillary acidic protein (GFAP)) and neuronal/axonal (ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), neurofilament light chain (NFL), and total-tau (t-tau)) proteins were measured in serum of 21 patients for up 5 days after injury using single molecule array (Simoa) technology. Group-based trajectory analysis was used to generate distinct temporal exosomal biomarker profiles. We found altered profiles of serum brain injury exosomal proteins following injury. The dynamics and levels of exosomal and related free-circulating markers, although correlated, showed differences. Patients with diffuse injury displayed higher acute exosomal NFL and GFAP concentrations in serum than those with focal lesions. Exosomal UCH-L1 profile characterized by acutely elevated values and a secondary steep rise was associated with early mortality (n = 2) with a sensitivity and specificity of 100%. Serum brain injury exosomal proteins yielded important diagnostic and prognostic information and represent a novel means to unveil underlying pathophysiology in patients with moderate-to-severe TBI. Our findings support their utility as potential tools to improve patient phenotyping in clinical practice and therapeutic trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
Maas, A. I. R., Menon, D. K., Adelson, P. D., Andelic, N., Bell, M. J., Belli, A., Bragge, P., Brazinova, A., Büki, A., Chesnut, R. M., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30371-x · Cited by 2,609
Self-citationNeurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988 · cited 1×
“It is well known that blood NFL is a sensitive indicator of axonal injury and a promising candidate for clinical application [31]; nonetheless, this is, to our knowledge, the first study to show”
BackgroundPrognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
Steyerberg, E. W., Moons, K. G. M., van der Windt, D. A., Hayden, J. A., Perel, P., Schroter, S., Riley, R. D., Hemingway, H., Altman, D. G., & for the PROGRESS Group (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001381 · Cited by 1,508 · cited 1×
“The present work, consistent with previous research [36,39], provides evidence that blood-based biomarkers, rooted in the disease mechanisms, may yield independent and complementary prognostic information, and supports their integration into novel comprehensive multidimensional approaches for outcome prediction.”
ResultExtracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
Thompson, A. G., Gray, E., Heman-Ackah, S. M., Mäger, I., Talbot, K., Andaloussi, S. E., Wood, M. J., & Turner, M. R. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.68 · Cited by 431 · cited 1×
“The complex and varied biogenesis underpinning the release of circulating exosomal brain injury proteins, along with their potential double-edged role in the contexts of the pathobiology of TBI [21,29], can provide a possible explanation for the observed absence of a correlation between exosomal markers, and injury se…”
BackgroundNew windows into the brain: Central nervous system-derived extracellular vesicles in blood
Shi, M., Sheng, L., Stewart, T., Zabetian, C. P., & Zhang, J. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.005 · Cited by 181 · cited 3×
“Thus, it is plausible that exosome secreted following acute TBI could function as a means to dispose and export excess of cellular material/components—products of the disease process or of disease-induced damage [20,21] that may exert long-distance pleiotropic regulatory effects (e.”
BackgroundAcute Serum Hormone Levels: Characterization and Prognosis after Severe Traumatic Brain Injury
Wagner, A. K., McCullough, E. H., Niyonkuru, C., Ozawa, H., Loucks, T. L., Dobos, J. A., Brett, C. A., Santarsieri, M., Dixon, C. E., Berga, S. L., et al. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1586 · Cited by 172 · cited 1×
“The trajectories are identified on a likelihood basis using methods previously described [16,17].”
MethodGlial fibrillary acidic protein elevations relate to neuroimaging abnormalities after mild TBI
Gill, J., Latour, L., Diaz-Arrastia, R., Motamedi, V., Turtzo, C., Shahim, P., Mondello, S., DeVoto, C., Veras, E., Hanlon, D., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006321 · Cited by 153
Self-citationSword, J., Masuda, T., Croom, D., & Kirov, S. A. (2013) · Brain · doi:10.1093/brain/awt026 · Cited by 81
New astroglial injury-defined biomarkers for neurotrauma assessment
Halford, J., Shen, S., Itamura, K., Levine, J., Chong, A. C., Czerwieniec, G., Glenn, T. C., Hovda, D. A., Vespa, P., Bullock, R., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17724681 · Cited by 75
Self-citationExtracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury
Mondello, S., Thelin, E. P., Shaw, G., Salzet, M., Visalli, C., Cizkova, D., Kobeissy, F., & Buki, A. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1464914 · Cited by 53 · cited 1×
“Exosomes, small secreted extracellular vesicles, are emerging as a new promising diagnostic and predictive class of blood biomarkers [6,7].”
BackgroundSelf-citation
Cited by
Extracellular Vesicle Proteins and MicroRNAs as Biomarkers for Traumatic Brain Injury
Guedes, V. A., Devoto, C., Leete, J., Sass, D., Acott, J. D., Mithani, S., & Gill, J. M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00663 · Cited by 85
“(171) explored longitudinal trajectories of serum EV levels of proteins and their freecirculating counterpart in moderate-to-severe TBI for up to 5 days after injury.”
BackgroundSelf-citationBidirectional Brain-Systemic Interactions and Outcomes After TBI
Faden, A. I., Barrett, J. P., Stoica, B. A., & Henry, R. J. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.12.004 · Cited by 57
Monteiro-Reis, S., Carvalho-Maia, C., Bart, G., Vainio, S. J., Pedro, J., Silva, E. R., Sales, G., Henrique, R., & Jerónimo, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063267 · Cited by 21
Guedes, V. A., Mithani, S., Williams, C., Sass, D., Smith, E. G., Vorn, R., Wagner, C., Lai, C., Gill, J., & Hinson, H. E. (2022) · Neurotrauma Reports · doi:10.1089/neur.2022.0058 · Cited by 15
Self-citationGhosh, S., & Ghosh, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878058 · Cited by 13
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Metadata
- Authors
- Mondello, S., Guedes, V. A., Lai, C., Czeiter, E., Amrein, K., Kobeissy, F., Mechref, Y., Jeromin, A., Mithani, S., Martin, C., Wagner, C. L., Czigler, A., Tóth, L., Fazekas, B., Buki, A., & Gill, J.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-04-15
- Volume
- 9
- Issue
- 4
- Pages
- 977
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3016728765
- Cited by
- 70
- References
- 10
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.